Naveris
is a Massachusetts-based biotechnology company that provides blood tests for early diagnosis and monitoring of response in patients undergoing treatment for cancer... Read moreNaveris
is a Massachusetts-based biotechnology company that provides blood tests for early diagnosis and monitoring of response in patients undergoing treatment for cancer... Read more
News
Apr 30, 2026
FierceBiotech
Naveris: CareDx expands into cancer testing with $260M Naveris buy .
Apr 29, 2026
Medical Device Network
Naveris: CareDx sharpens precision medicine focus with $260m Naveris acquisition
Jan 09, 2026
StreetInsider
Press Release: Naveris : Naveris to Highlight New Publications at the 44th Annual J.P. Morgan Healthcare Conference
Apr 30, 2025
Naveris Youtube Channel
Naveris posted a video "What it means to confront cancer with clarity, confidence and without regrets" on YOUTUBE
Jan 10, 2025
Business Wire
Press Release: Naveris : Naveris Announces Expansion of the NavDx Test in Anal Cancer Molecular Residual Disease Surveillance
Oct 09, 2024
StreetInsider
Press Release: Naveris : Naveris Announces Expanded Commercial Payor Coverage for NavDx Test from Blue Shield of California
Sep 28, 2024
StreetInsider
Press Release: Naveris : Naveris to Showcase Advances in Precision Surveillance for HPV-Associated Oropharyngeal Cancer Using the NavDx Test at the 2024 ASTRO Annual Meeting
May 29, 2024
Business Wire
Press Release: Naveris : Naveris to Present New Data Highlighting Clinical Utility of the NavDx Test at the 2024 ASCO Annual Meeting
Apr 24, 2024
Business Wire
Press Release: Naveris : Naveris Announces Launch of Phase II Clinical Study in MRD+ Head and Neck Cancer
Mar 22, 2024
Medical Device Network
Naveris: Naveris' NavDx test secures CMS ADLT status
